Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia

Cerebral Cortex

Volumn 11, Issue 2, 2001, Pages 136-147

  Weickert, Cynthia Shannon ^a,d   Webster, Maree J ^b   Hyde, Thomas M ^a   Herman, Mary M ^a   Bachus, Susan E ^a   Bali, Geetha ^c   Weinberger, Daniel R ^a   Kleinman, Joel E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Stanley Foundation   (United States)

^c BANGALORE UNIVERSITY   (India)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; MESSENGER RNA; NEUROMODULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NORTHERN BLOTTING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; SCHIZOPHRENIA;

EID: 0035152440     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/11.2.136     Document Type: Article

References (71)

1. Depletion of 43-Kd growth-associated protein in primary sensory neurons leads to diminished formation and spreading of growth cones
2. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones
3. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
4. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London
5. Columnar aggregation of prefrontal and anterior cingulate cortical cells projecting to the thalamic mediodorsal nucleus in the monkey
6. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey
7. Pre- and postmortem influences on brain RNA
8. GAP-43: An intrinsic determinant of neuronal development and plasticity
9. Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex
10. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging
11. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study
12. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia
13. Preliminary evidence: Decreased GAP43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus
14. Hippocampal and cortical growth. Associated protein-43 messenger RNA in schizophrenia
15. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes
16. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task
17. Functional interactions between inferotemporal and prefrontal cortex in a cognitive task
18. PET brain mapping study of auditory verbal supraspan memory versus visual fixation in schizophrenia
19. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
20. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: Regional and diagnostic specificity
21. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia
22. Neurocognitive deficits in schizophrenia
23. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory
24. Working memory dysfunction in schizophrenia
25. Functional and anatomical aspects of prefrontal pathology in schizophrenia
26. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins
27. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
28. Developmental changes revealed by immunohistochemical markers in human cerebral cortex
29. A protein associated with axon growth, GAP43, is widely distributed and developmentally regulated in rat CNS
30. Multiplex solution hybridization-ribonuclease protection assay for quantification of different ribonucleic acid transcripts from snap-frozen neuroendocrine tissues of individual animals
31. Extensive postmortem stability of RNA from rat and human brain
32. GAP-43 mRNA expression in early development of human nervous system
33. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: A possible neurochemical basis for 'hypofrontality'
34. Psychiatric diagnosis after death: The problems of accurate diagnosis from case history review and relative interviews
35. Methodological issues in the neuropathology of mental illness
36. Human GAP-43: Its deduced amino acid sequence and chromosomal localization in mouse and human
37. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-α mRNA in mouse brain by a quantitative nuclease protection assay
38. Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 and 46)
39. Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia
40. Targeting of neuromodulin (GAP-43) fusion proteins to growth cones in cultured rat embryonic neurons
41. Direct relation of long-term synaptic potentiation to phosphorylation of membrane protein F1, a substrate for membrane protein kinase C
42. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
43. The problem of the frontal lobe: A reinterpretation
44. Characterization of protein F 1 (47 kDa, 4.5 pI): A kinase C substrate directly related to neural plasticity
45. Gradients of protein kinase C substrate phosphorylation in primate visual system peak in visual memory storage areas
46. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain
47. The neuronal growth-associated protein GA P-43 (B-50, F1): Neuronal specificity, developmental regulation and regional distribution of human and rat mRNAs
48. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors
49. Schizophrenia: A disease of heteromodal association cortex?
50. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
51. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria
52. Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease
53. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17
54. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method
55. Inhibition of neurite outgrowth following intracellular delivery of anti-GAP-43 antibodies depends upon culture conditions and method of neurite induction
56. Phospholipid-mediated delivery of anti-GAP-43 antibodies into neuroblastoma cells prevents neuritogenesis
57. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43
58. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia
59. Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia
60. Striatal TGF-alpha: Postnatal developmental expression and evidence for a role in the proliferation of subependymal cells
61. The neuroanatomy and neurochemistry of schizophrenia
62. A connectionist approach to the prefrontal cortex
63. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: A search for common ground
64. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
65. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
66. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol
67. Laminar origin of striatal and thalamic projections of the prefrontal cortex in rhesus monkeys
68. The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells